FDA Approves Drug For Treatment Of Children And Infants With HIV

Reuters (6/12, Singh) reported the FDA approved GlaxoSmithKline’s Tivicay (dolutegravir) and Tivicay PD tablets to treat children and infants with HIV. The agency granted approval of the two tablets “for suspension to treat HIV-1 infection in pediatric pa...